Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a new supplement beat melatonin for deep sleep?

NCT ID NCT07600528

Symptom relief Sponsor: OmniSolutions Laboratory Holdings Limited Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This small study tested a dietary supplement called NatureU Sweet Dream, which contains GABA and Lactium, against a standard melatonin product in 17 adults with mild to moderate sleep problems. Participants wore a sleep tracker to measure deep sleep duration and percentage. No side effects were reported, but the study was very small and not blinded, so the results are preliminary.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NatureU Sweet Dream (GABA and Lactium dietary supplement)
What this could lead to
If it works, this could point toward a natural supplement option for improving deep sleep without the side effects of melatonin.
What could go wrong
This was a very small (17 participants), open-label, exploratory study with no blinding, so results may not be reliable or generalizable. The supplement is not a drug and has not been rigorously tested.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

17 people

The number who actually took part.

Started

Apr 2024

Finished

Apr 2024

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 44 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Signed informed consent before the study and understood the study content, procedures, and possible adverse reactions. * Adult participant with mild to moderate sleep disturbance. * Able and willing to use the wearable sleep monitoring device according to study instructions. * Able to maintain normal diet and routine habits during the study. * Able to avoid alcohol during the study period. * Able to avoid excessive exercise 2 hours before sleep during test nights. * Able to take the assigned product with warm water 1 hour before sleep during test nights. * Willing to complete the full study procedures and provide sleep monitoring data. Exclusion Criteria: * Known allergy or hypersensitivity to the study product, comparator product, or any related ingredients. * Severe sleep disorder or other condition judged by the investigator to make participation inappropriate. * Acute or chronic illness that could affect sleep assessment or participant safety. * Use of medications, supplements, or procedures that could affect sleep outcomes during the study period. * Alcohol intake or other behavior likely to interfere with sleep testing. * Inability to use the wearable monitoring device or mobile application as required. * Serious protocol deviation or inability to tolerate the test food. * Any factor that could seriously affect study results. * Any other reason judged by the investigator to require withdrawal or exclusion.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Sleep disturbance are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

insomnia Parasomnias sleep disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Sleep disturbance Sleep quality

Contacts and locations

Locations

  • Shanghai CTI Medical Laboratory

    Shanghai, Shanghai Municipality, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.